Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interventions for bullous pemphigoid.

N Khumalo1, G Kirtschig, P Middleton

  • 1Dermatology Department, Groote Schuur Hospital, Cape Town, South Africa, Anzio Road, Observatory, Cape Town, Western Cape, South Africa.

The Cochrane Database of Systematic Reviews
|August 15, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EuroGuiderm guideline on lichen sclerosus-introduction into lichen sclerosus.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

EuroGuiderm guideline on lichen sclerosus-Treatment of lichen sclerosus.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Mass deworming for soil-transmitted helminths and schistosomiasis among pregnant women: A systematic review and individual participant data meta-analysis.

Campbell systematic reviews·2023
Same author

Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV).

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

2021 European guideline for the management of vulval conditions.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Data of macroinvertebrates assemblage across different stretches of an urban Palmiet River in Durban, South Africa.

Data in brief·2021

Bullous pemphigoid treatments were reviewed, finding potent topical steroids effective for extensive disease. Lower oral steroid doses may suffice, reducing side effects, while other treatments require more research.

Area of Science:

  • Dermatology
  • Autoimmune Diseases
  • Clinical Trials

Background:

  • Bullous pemphigoid is the most prevalent autoimmune bullous disease in Western countries.
  • Oral corticosteroids are the established standard treatment for bullous pemphigoid.

Purpose of the Study:

  • To systematically evaluate the efficacy and safety of various treatments for bullous pemphigoid.
  • To compare different therapeutic strategies against bullous pemphigoid.

Main Methods:

  • Conducted a systematic review of randomized controlled trials (RCTs) up to March 2003.
  • Searched multiple databases including MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials.
  • Included RCTs of patients with immunofluorescence-confirmed bullous pemphigoid.

Related Experiment Videos

Main Results:

  • Seven RCTs involving 634 patients were analyzed; no placebo-controlled studies were found.
  • Potent topical corticosteroids demonstrated superior survival and disease control in extensive bullous pemphigoid compared to oral prednisone.
  • Azathioprine or plasma exchange added to corticosteroids did not show established benefits, though azathioprine reduced prednisone dosage requirements.

Conclusions:

  • Very potent topical steroids offer effective and safe treatment options for bullous pemphigoid, particularly in extensive cases.
  • Lower starting doses of oral prednisolone (below 0.75 mg/kg/day) may achieve disease control and reduce adverse reactions.
  • Combination therapies like tetracycline and nicotinamide show potential but require further validation.